Top300 Bio CDMO:设施索引和生物製造商註册资料库
年间契约型资讯服务
商品编码
1455820

Top300 Bio CDMO:设施索引和生物製造商註册资料库

Top300 Bio CDMO - Facility Index and Biomanufacturers Subscription Database

出版日期: 年间契约型资讯服务 | 出版商: BioPlan Associates, Inc. | 英文

价格
简介目录

该资料库是世界上唯一一个积极追踪400 多家提供生物製药开发和製造服务的公司的 CDMO 设施的合约开发和製造设施资料库。

全球有数百家工厂以临床和商业规模生产生物製剂,到 2023 年,它们总共将产生 168.9 亿美元的服务收入每年增长 17%。

该资料库基于30 年的生物製药和生命科学行业评估和基准,不断更新以包含全面的资讯和见解。

"Top300 Bio CDMO 设施指数" 对每个 "专用" CDMO 设施进行排名,并按区域提供生物製造区域/栅格的定量分析。

  • 生物反应器总容量
  • CDMO/CMO服务专业知识
  • 生物製造产能计画未来投产
  • 目前正在生产的商业和临床生物製药产品数量
  • 收入预测
  • 优势/挑战
  • 技术和专业知识等

如何使用top300biocdmo.com

  • 确定理想的 CDMO或合作伙伴
  • 确定您的专长:细胞治疗、基因治疗、pDNA、mRNA 等。
  • 早期公司:赞助商识别潜在的製造合作伙伴
  • 设施选址:确保优秀员工并减少就业问题
  • 分配销售区域:决定区域的位置和人员配置
  • 市场竞争:识别 CDMO 竞争对手的优势和劣势
  • 房地产评估:基于设施相关和区域吸引力
  • 人力资源和招募经理:确定所需的受过高等教育和技术熟练的员工的最低数量
  • 产业成长:寻找产业成长最快的地区
  • 新兴地区:中国、印度、拉丁美洲和中东的 CDMO 设施
  • CDMO公司排名: CDMO设施在技能、就业和生产能力方面的排名
简介目录

The only Global Contract Development and Manufacturing Facilities Database subscription that actively tracks over 400+ dedicated CDMO facilities providing development and manufacturing services for biopharmaceuticals.

Hundreds of facilities manufacturing clinical and commercial scale biologics, account for $16.89 billion in services sales in 2023, growing at 17% annually.

Based on 30 years of evaluating and benchmarking the biopharmaceutical and life sciences industry, this database is updated continually and includes comprehensive information and insights.

"Top300 Bio CDMO Facility Index" ranks each 'dedicated' CDMO facility and provides regional quantitative analysis of biomanufacturing regions and clusters.

  • Total bioreactor liter capacity
  • CDMO/CMO service expertise
  • Future Biomanufacturing capacity coming online
  • Number of commercial and clinical biological products manufactured
  • Revenue estimates
  • Strengths and Challenges
  • Technologies and expertise, and much more

USES FOR THE TOP300BIOCDMO.COM

  • Identify your ideal CDMO or partners
  • Identify specialized expertise such as cell or gene therapy, pDNA, mRNA
  • Early-stage companies: sponsors can identify potential manufacturing partners
  • Facility siting: Locate qualified employees; reduce hiring challenges
  • Sales territory allocations: Determine where and how to staff territories
  • Market Competition: Identify CDMO competitors' strengths and weaknesses
  • Real estate valuation: For facilities, based on regional attractiveness
  • HR and Recruiters: Looking for a critical mass of educated and skilled staff
  • Industry Growth: Find where the industry is growing most rapidly
  • Emerging Regions: CDMO Facilities in China, India, Latin America, Middle East regions
  • CDMO Company Ranking: How do CDMO facilities rank, in skills, employment, capacity